| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 46.302 | 52.519 | 56.599 | 61.534 | 68.535 | 77.748 | 90.169 | 87.610 | 107.084 | 124.223 |
| Total Income - EUR | 46.302 | 52.519 | 56.599 | 63.551 | 70.271 | 77.748 | 90.170 | 87.611 | 107.084 | 124.224 |
| Total Expenses - EUR | 40.771 | 42.016 | 44.728 | 55.243 | 56.867 | 65.693 | 82.841 | 71.879 | 85.015 | 97.614 |
| Gross Profit/Loss - EUR | 5.532 | 10.503 | 11.872 | 8.308 | 13.404 | 12.055 | 7.329 | 15.732 | 22.069 | 26.610 |
| Net Profit/Loss - EUR | 4.142 | 9.976 | 11.306 | 7.673 | 12.701 | 11.521 | 6.510 | 14.856 | 21.210 | 24.063 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medoptica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 54.556 | 57.883 | 71.474 | 106.267 | 95.765 | 93.949 | 93.904 | 94.195 | 96.338 | 88.146 |
| Current Assets | 26.184 | 30.868 | 37.700 | 30.515 | 26.543 | 28.276 | 25.791 | 18.191 | 38.487 | 27.529 |
| Inventories | 24.591 | 28.044 | 33.983 | 29.244 | 24.802 | 21.759 | 17.756 | 16.795 | 14.297 | 18.379 |
| Receivables | 0 | 0 | 0 | 428 | 0 | 0 | 788 | 0 | 363 | 560 |
| Cash | 1.593 | 2.824 | 3.717 | 843 | 1.741 | 6.517 | 7.247 | 1.396 | 23.827 | 8.590 |
| Shareholders Funds | 47.987 | 57.473 | 82.376 | 88.537 | 83.762 | 93.695 | 98.127 | 89.766 | 110.704 | 113.039 |
| Social Capital | 6.974 | 6.903 | 6.786 | 6.662 | 6.533 | 6.409 | 6.267 | 6.286 | 6.267 | 6.232 |
| Debts | 32.753 | 31.278 | 26.798 | 48.245 | 38.546 | 28.530 | 21.568 | 22.621 | 24.122 | 2.637 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Medoptica S.r.l.